Omeros reported $-4925000 in Equity Capital and Reserves for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Equity Capital And Reserves Change
Acelrx Pharmaceuticals ACRX:US $ -38.27M 2.38M
Adma Biologics ADMA:US $ 126.93M 14.24M
Aerie Pharmaceuticals AERI:US $ -125.71M 108.38M
Alnylam Pharmaceuticals ALNY:US $ 401.17M 187.04M
Biomarin Pharmaceutical BMRN:US $ 4391.31M 120.58M
Cytokinetics CYTK:US $ 116.26M 127.6M
Dynavax Technologies DVAX:US $ 287.48M 65.11M
Gilead Sciences GILD:US $ 19927M 1142M
Heron Therapeutics HRTX:US $ 23.96M 53.61M
Insmed INSM:US $ 119.88M 290.59M
Intercept Pharmaceuticals ICPT:US $ -371.76M 187.8M
Knight Therapeutics Inc GUD:CN C$ 829.58M 12.44M
Macrogenics MGNX:US $ 178.21M 61.4M
Mirati Therapeutics MRTX:US $ 1249.28M 147.76M
Omeros OMER:US $ -4925000 28.7M
Pacira Pharmaceuticals PCRX:US $ 709.58M 20.83M
Pfizer PFE:US $ 82424M 5224M
Regulus Therapeutics RGLS:US $ 49.24M 5.72M
Sangamo Biosciences SGMO:US $ 334.52M 40.82M
Sarepta Therapeutics SRPT:US $ 856.89M 71.12M
United Therapeutics UTHR:US $ 4176.3M 217.4M
Vertex Pharmaceuticals VRTX:US $ 10907M 807M
Vital Therapies VTL:US $ 137.96M 10.85M
Xoma XOMA:US $ 139.92M 1.95M